M.A. Med Alliance S.A.
Clinical trials sponsored by M.A. Med Alliance S.A., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New balloon treatment could save legs from amputation Results expected Jun 2027 (estimated)
- New balloon treatment could open clogged small heart arteries without stents Results expected Jun 2027 (estimated)
-
Heart artery showdown: balloon vs. stent in major new trial
Disease control OngoingThis study compares two ways to treat coronary artery disease (blocked heart arteries). One uses a balloon coated with medicine (Selution DEB) to open the blockage, and the other uses a small mesh tube (stent) that also releases medicine (DES). About 3,300 adults with chest pain …
Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug balloon could keep leg arteries open longer
Disease control OngoingThis study tests a special balloon coated with a drug (SELUTION SLR™ 018) to open narrowed leg arteries in people with peripheral arterial disease. About 300 participants will be randomly assigned to receive either the drug-coated balloon or a standard uncoated balloon. The goal …
Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New balloon could unclog failed heart stents without extra metal
Disease control OngoingThis study tests a special balloon coated with the drug sirolimus to treat in-stent restenosis, where a previously placed stent in a heart artery becomes blocked again. About 418 adults with this condition will be randomly assigned to receive either the drug-coated balloon or sta…
Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New balloon treatment for leg artery disease tracked in large Real-World study
Disease control OngoingThis study is tracking how well a drug-coated balloon called SELUTION SLR works in real-world patients with peripheral artery disease (PAD). The balloon is inflated in narrowed leg arteries to open them and release a drug that helps keep them open. Researchers are following 723 p…
Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC